What is Fuss Brands Corp.?
It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction.
FBDS · Verdict
Moderate reward · high risk
FBDS's standout is volatility; cash flow and balance sheet weigh on the picture.
Based on 88% data coverage
FBDS · Verdict
Above average
Weak vs peers
Current ratio 0.00
0% return on equity
Earnings +103.9% CAGR
Model-based scoring. For information only — not financial advice.
It intends to explore and identify business opportunities within the United States, including a potential acquisition of an operating entity through a reverse merger, asset purchase, or similar transaction. The company was formerly known as China Botanic Pharmaceutical Inc. The company is listed on the PINK in USA, operating in the Financial Services sector, with a market capitalisation of 1.44M.
The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.